Related Experiment Videos
Theophylline toxicity in a preterm infant: selected clinical aspects
Pediatric Pharmacology (New York, N.Y.)
|January 1, 1985
Summary
Parent-induced theophylline toxicity occurred in a preterm infant with high drug levels but no seizures. Activated charcoal may enhance clearance, but more research is needed.
Area of Science:
- Pediatric Pharmacology
- Neonatal Toxicology
- Clinical Pharmacy
Background:
- Theophylline is a medication used for respiratory conditions in infants.
- Accidental or intentional overdose can lead to severe toxicity.
- Preterm infants may have altered drug metabolism and excretion.
Observation:
- A case of parent-induced theophylline toxicity in a preterm infant is presented.
- The infant presented with a high theophylline serum level (97 mcg/ml).
- Notably, no clinical seizure activity was observed despite the elevated level.
Findings:
- Pharmacokinetic data suggested that oral activated charcoal administration may have accelerated theophylline clearance.
- This observation implies a potential therapeutic role for activated charcoal in managing theophylline toxicity.
- Further investigation is required to validate this finding and establish optimal protocols.
Implications:
- Activated charcoal could be a potential adjunct therapy for theophylline toxicity in neonates.
- Careful patient and caregiver education is crucial to prevent medication dosing errors.
- This case highlights the importance of monitoring drug levels and clinical presentation in neonatal toxicology.